Cargando…
Health care utilization and costs following amplified versus non-amplified molecular probe testing for symptomatic patients with suspected vulvovaginitis: a US commercial payer population
BACKGROUND: Vulvovaginitis (VV) is a common reason women seek medical attention in the USA. Both the non-specific clinical presentation and risk of preterm labor or delivery necessitate accurate identification of the causative agents to guide appropriate therapy. The diagnostic accuracy of amplified...
Autores principales: | Ackerman, Stacey J, Knight, Tyler, Wahl, Peter M, Cartwright, Charles P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388970/ https://www.ncbi.nlm.nih.gov/pubmed/30863131 http://dx.doi.org/10.2147/CEOR.S191831 |
Ejemplares similares
-
Management of sacroiliac joint disruption and degenerative sacroiliitis with nonoperative care is medical resource-intensive and costly in a United States commercial payer population
por: Ackerman, Stacey J, et al.
Publicado: (2014) -
Comparison of the costs of nonoperative care to minimally invasive surgery for sacroiliac joint disruption and degenerative sacroiliitis in a United States commercial payer population: potential economic implications of a new minimally invasive technology
por: Ackerman, Stacey J, et al.
Publicado: (2014) -
Cost–effectiveness of overactive bladder treatments from a US commercial and payer perspective
por: Murray, Brian, et al.
Publicado: (2023) -
Radiation tests on commercial instrumentation amplifiers, analog switches & DAC's
por: Agapito, J A, et al.
Publicado: (2001) -
Comment on: “Cost-Utility Analysis of Duloxetine in Osteoarthritis: A US Private Payer Perspective”
por: Liedgens, Hiltrud, et al.
Publicado: (2013)